973 related articles for article (PubMed ID: 16882819)
1. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
[TBL] [Abstract][Full Text] [Related]
2. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.
Schuh S; Reisman J; Alshehri M; Dupuis A; Corey M; Arseneault R; Alothman G; Tennis O; Canny G
N Engl J Med; 2000 Sep; 343(10):689-94. PubMed ID: 10974132
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
5. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
[TBL] [Abstract][Full Text] [Related]
7. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
Rice-McDonald G; Bowler S; Staines G; Mitchell C
Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
[TBL] [Abstract][Full Text] [Related]
8. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
10. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial.
von Berg A; Gappa M; Steinkamp G;
Eur J Med Res; 2002 Jun; 7(6):257-64. PubMed ID: 12117660
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
13. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
Masoli M; Weatherall M; Holt S; Beasley R
Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
[TBL] [Abstract][Full Text] [Related]
14. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
Sheffer AL; LaForce C; Chervinsky P; Pearlman D; Schaberg A
J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
[TBL] [Abstract][Full Text] [Related]
16. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
18. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
19. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
20. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]